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1. Introduction
Apoptosis is a tightly regulated process character-
ized by cell shrinkage, plasma membrane blebbing, 
and chromatin condensation that is consistent with 
DNA cleavage into ladders [1,2]. Apoptosis plays 
an important role in developmental processes, 
maintenance of homeostasis, and elimination of 
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damaged cells. Several gene products have been 
demonstrated to be critical in the regulation of 
apoptosis. For instance, caspases, a group of cysteine 
proteases, play key roles in apoptosis [3,4]. Caspases 
are synthesized as proenzymes, which are activated 
by the cleaving of the prodomain at a specific as-
partic acid cleaving site [5,6]. Caspase activation is 
often regulated by various cellular factors, including 
members of the Bcl-2 family and/or death receptor-
related gene products [6−9]. However, most can-
cer cells can block apoptosis, which allows them to 
survive despite genetic and morphologic transfor-
mations. Many recent studies have shown that many 
chemopreventive and/or chemotherapeutic agents 
can cause tumor cell death via the induction of ap-
optosis, which is the preferred method of manag-
ing cancer. Therefore, the induction of apoptotic 
cell death is an important mechanism in the anti-
cancer properties of many drugs.
In Chinese traditional medicine, amphibian skin 
extract has been used for the alleviation of many 
human ailments. Toads, particularly members of the 
genus Bufo, are identified as a particularly useful 
and readily available source of granular gland se-
cretions, which commonly contain biogenic amines, 
bufodienolides, alkaloids and steroids, peptides 
and proteins [10,11]. Chan Su (Venenum Bufonis) 
is the dried white venom prepared from the skin 
secretions of a toad (Bufo bufo gargarizans Cantor), 
which has been used in China and other Asian coun-
tries for centuries to treat a number of diseases, 
including cancer, arrhythmia and other heart dis-
eases [12,13]. In several previous reports, Chan Su 
has been shown to be potent in the treatment of 
various cancer cells in vitro by induction of cell 
cycle arrest and apoptosis [14−21]. Recently, we 
also reported that Chan Su is significant in induc-
ing the apoptosis against human bladder carcinoma 
cells, which was mediated by an increase in Bax 
expression, decrease in Bcl-2 expression and a pro-
teolytic activation of caspase-3 and -9 [22]. The 
apoptotic effects of Chan Su were also associated 
with a specific inhibition of COX-2 expression and 
prostaglandin E2 production [22]. However, the 
molecular mechanisms of its anti-proliferative ac-
tion on malignant cell growth are not completely 
understood.
In the present study, to further evaluate the 
cyto toxic effects of Chan Su in cancer cells, the 
effects of an extract of Chan Su (skin of Venenum 
Bufonis, SVB) on apoptosis in human lung carci-
noma A549 cells were investigated. We found that 
SVB-induced-apoptosis is accompanied by modula-
tion of the death receptor system, Bcl-2 family 
members, mito chondrial dysfunction and activation 
of caspases.
2. Materials and Methods
2.1.  Cell culture, SVB treatment, and 
cell growth assay
Human lung carcinoma A549 cells were obtained 
from the American Type Culture Collection 
(Rockville, MD, USA) and cultured in RPMI1640 me-
dium (Gibco BRL, Gaithersburg, MD, USA) supple-
mented with 10% heat-inactivated fetal bovine 
serum (FBS, Gibco BRL), 2 mM glutamine, 100 U/mL 
penicillin, and 100 μg/mL streptomycin in a humid-
ified environment with 5% CO2 at 37ºC. The SVB was 
obtained from Dunsan Oriental Hospital (Daejeon, 
South Korea). One hundred grams of SVB was washed 
with distilled water, and then boiled in 1 L water at 
80ºC for 2.5 hours. Solid particles and aggregates 
were removed by centrifugation at 3,000g for 30 
minutes and the supernatants were lyophilized. 
Finally, 21.7g lyophilized SVB were obtained and 
used in this experiment. The lyophilized extract 
was stored at −20ºC until used. For growth inhibi-
tion studies, cells were cultured in the absence 
and presence of variable concentrations of SVB for 
24 hours. The cells were trypsinized, washed with 
phosphate-buffered saline (PBS), and the viable cells 
were scored with a hemocytometer through the 
exclusion of trypan blue. Measurement of cell viabil-
ity was determined using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide (MTT, Sigma 
Chemical Co., St. Louis, MO, USA) assay, which is 
based on the conversion of MTT to MTT-formazan 
by mitochondrial enzymes [23]. For morphological 
studies, the cells were treated with SVB for 24 
hours and directly photographed with an inverted 
microscope (Carl Zeiss, Germany).
2.2. Nuclear staining with DAPI
For evidence of apoptosis, morphological changes of 
nuclei were visualized following DNA staining using 
the fluorescent dye 4,6-diamidino-2-phenylindole 
(DAPI, Sigma). After incubation for 24 hours with 
SVB, cells were fixed with 3.7% paraformaldehyde 
for 20 minutes at room temperature, and washed 
with PBS. Cells were then stained with 2.5 μg/mL 
DAPI solution for 10 minutes at room temperature. 
The cells were then washed twice with PBS and 
stained nuclei were observed using fluorescence 
microscopy (Carl Zeiss).
2.3. DNA flow cytometric analysis
After treatment with SVB, cells were harvested, 
washed twice with ice-cold PBS, fixed with 75% 
ethanol at 4ºC for 30 minutes, and stained using 
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a DNA staining kit (CycleTEST PLUS Kit, Becton 
Dickinson, San Jose, CA, USA) with propidium iodide 
(PI). DNA content at sub-G1 phase was then deter-
mined by flow cytometry (FACSCalibur) and ana-
lyzed by Cell Quest software (Becton Dickinson).
2.4.  Mitochondrial membrane potential 
(MMP, Ψm) assay
To measure the MMP, 5,5,6,6-Tetrachloro-1,1,3,3-
tetraethylbenzimidazolylcarbocyanine iodide (JC-1, 
Calbiochem, San Diego, CA, USA), a dual-emission 
fluorescent dye, was used. JC-1 is internalized and 
concentrated by respiring mitochondria and can 
reflect changes in MMP in living cells. There are 
two excitation wavelengths, 527 nm (green) for the 
monomer form and 590 nm (red) for the JC-1 ag-
gregate form. Briefly, the cells were collected and 
incubated with 10 μM JC-1 for 30 minutes at 37ºC. 
Cells were then washed once with cold PBS and 
analyzed using a DNA flow cytometer.
2.5.  Protein extraction and western blot 
analysis
Cells were collected with ice-cold PBS, and imme-
diately lysed with lysis buffer (20 mM sucrose, 1 mM 
EDTA, 20 μM Tris-Cl, pH 7.2, 1 mM DTT, 10 mM KCl, 
1.5 mM MgCl2, containing protease inhibitors (5 μg/
mL pepstatin A, 10 μg/mL leupeptin, and 2 μg/mL 
aprotinin). Protein concentrations were determined 
using Bio-Rad protein assay kits (Bio-Rad, Hercules, 
CA, USA). After normalization, total proteins were 
subjected to sodium dodecyl sulfate (SDS)-poly-
acrylamide gels and then transferred to a nitro-
cellulose membrane (Schleicher & Schuell, Keene, 
NH, USA) via electroblotting. The membrane was 
blocked with 5% skim milk, and incubated with the 
primary antibodies and HRP-conjugated anti-mouse 
and anti-rabbit secondary antibodies. The target pro-
teins were visualized by an enhanced chemilumines-
cence (ECL, Thermo scientific, Rockford, IL, USA) 
detection system. Antibodies were purchased from 
Calbiochem (San Diego, CA, USA) and Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Peroxidase-
labeled donkey anti-rabbit and sheep anti-mouse 
immunoglobulin were purchased from Amersham 
(Arlington Heights, IL, USA).
2.6. Assay of caspases activity
The enzymatic activity of caspases that had been 
induced by SVB was recorded using colorimetric 
assay kits based on the manufacturer’s protocol 
(R&D Systems, Minneapolis, MN, USA). Briefly, cells 
were lysed in a lysis buffer for 30 minutes on an ice 
bath. The lysed cells were centrifuged at 14,000 rpm 
for 10 minutes, and 100 μg protein was incubated 
with 50 μL of reaction buffer and 5 μL of colorimetric 
tetrapeptides, Asp-Glu-Val-Asp (DEVD)-p-nitroanilide 
(pNA) for caspase-3, Ile-Glu-Thr-Asp (IETD)-pNA 
for caspase-8 and Leu-Glu-His-Asp (LEHD)-pNA for 
caspase-9 at 37ºC for 2 hours. The optical density 
of the reaction mixture was measured by changes in 
absorbance at 405 nm using a VersaMax tunable 
microplate reader (Molecular Devices, Palo Alto, 
CA, USA).
2.7. Statistical analysis
The data is expressed as means ± SD. Statistical 
comparisons were performed using one-way ANOVA 
followed by a Fisher test. Significant differences 
between the groups were determined using an un-
paired Student’s t-test. A p value < 0.05 was con-
sidered significant.
3. Results
3.1.  Growth inhibition and apoptosis 
induction by SVB in A549 cells
To determine if SVB decreases cell growth, A549 
cells were stimulated with various concentrations 
of SVB and the cell number and viability were then 
measured by trypan blue exclusion method and 
MTT assay. As shown in Figure 1, treatment with 
SVB significantly inhibited the viability and prolif-
eration of cells, and these effects occurred in a 
concentration-dependent manner. In addition, di-
rect observation by inverted microscopy revealed 
that numerous morphological changes occurred in 
cells treated with SVB (Figure 2A). In particular, 
cell shrinkage, cytoplasm condensation, and for-
mation of cytoplasmic filaments appeared in a 
concentration-dependent manner after SVB treat-
ment. To elucidate whether SVB inhibits the prolif-
eration of A549 cells by inducing apoptosis, cells 
treated with SVB were examined after DAPI stain-
ing. The control cells displayed an intact nuclear 
structure; whereas, cells treated with SVB had 
chromosomal condensation and formation of apop-
totic bodies (Figure 2B). Thus, the degree of apop-
tosis was determined by analyzing the amount of 
sub-G1 DNA in A549 cells that were treated with 
SVB using flow cytometry. As shown in Figure 2C, 
the treatment of A549 cells with SVB resulted in 
the increased accumulation of cells in the sub-G1 
phase. Taken together, these results suggest that 
A549 cells can undergo apoptosis after being ex-
posed to SVB. In addition, these results revealed a 
good correlation between the extent of apoptosis 
and the inhibition of growth.
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3.2.  Effects of SVB on the levels of 
apoptosis-related genes in A549 cells
To investigate the apoptotic pathways activated 
by SVB, we used Western blot analysis to measure 
the expression of the death receptors and corre-
sponding pro-apoptotic ligands (Fas, FasL, TRAIL, 
DR4 and DR5), as well as the expression of the 
Bcl-2 family members (Bcl-2, Bcl-xL, Bax, Bad and 
Bid). As shown in Figure 3, the protein levels of 
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Figure 1 Inhibition of the cell growth by SVB in A549 human lung carcinoma cells. The cells were plated at 4 × 104 
cells per 60 mm plate, and incubated for 24 hours. The cells were treated with varying concentrations of SVB for 
24 hours and cell viability and growth inhibition were, respectively, measured by the metabolic-dye-based MTT assay (A) 
and hemocytometer counts of trypan blue-excluding cells (B). Data is expressed as mean ± SD of three independent 
experiments. Statistical analysis was carried out by t-test (*, p < 0.05).
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Figure 2 Induction of apoptosis by SVB treatment in A549 cells. (A and B) After treating the cells with SVB for 
24 hours, they were observed using an inverted microscope (A, magnification, ×200) or were stained with DAPI for 
10 minutes, washed with PBS, and then photographed with a fluorescence microscope using a blue filter (B, magnifi-
cation, ×400). (C) To quantify the degree of apoptosis induced by SVB, the cells were evaluated for sub-G1 DNA con-
tent using a flow cytometer. This represents the fractions undergoing apoptotic DNA degradation. Each point 
represents the average of two independent experiments.
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FasL and DR4 expression were markedly increased 
in the SVB-treated A549 cells, whereas the levels 
of anti-apoptotic Bcl-2 expression were significantly 
inhibited in response to the SVB treatment in a 
concentration-dependent manner. However, the lev-
els of Fas, DR5, TRAIL, Bcl-xL, Bax and Bad expres-
sion were relatively unchanged in response to SVB 
treatment. Additionally, Western blot analyses re-
vealed that treatment with SVB induced the cleav-
age of Bid (tBid), a BH3-only pro-apoptotic member 
of the Bcl-2 family. This data indicates that both the 
extrinsic and intrinsic pathways might be involved 
in SVB-induced apoptosis in A549 cells. The expres-
sion levels in the SVB-treated cells were also exam-
ined to determine if SVB induces A549 cell death 
through a change in the expression of the inhibitor 
of apoptosis (IAP) family proteins, which binds the 
caspases and leads to caspase inactivation for an 
anti-apoptotic effect. As shown in Figure 3, SVB in-
duced a concentration-dependent decrease in the 
expression levels of the XIAP, cIAP-1 and cIAP-2 
proteins.
3.3.  Loss of MMP and activation of 
caspases by SVB
The role of the mitochondria in SVB-induced apop-
tosis was further investigated by examining the 
effect of SVB on the MMP and caspase activity in 
A549 cells. Exposure of A549 cells to various con-
centrations of SVB led to a significant reduction in the 
level of MMP, and this reduction occurred in a dose-
dependent manner (Figure 4). In addition, SVB treat-
ment resulted in down-regulation of pro-caspase-3, 
-8 and -9 (Figure 5A). To further quantify the proteo-
lytic activation of the caspases, the concentration 
of protein in the lysates of cells treated with SVB was 
normalized and then assayed for their caspase-3, -8 
and -9 activity using DEVD-pNA, IETD-pNA and LEHD-
pNA, respectively, as substrates. As shown in Figure 5B, 
Fas Bcl-2
cIAP-2
cIAP-1
xIAP
Bid
Bad
Bax
Bcl-xL
0 1 2
SVB (μg/mL)
3 4 5
FasL
DR4
DR5
TRAIL
Actin
0 1 2
SVB (μg/mL)
3 4 5
Figure 3 Effects of SVB on the levels of apoptosis-related genes in A549 cells. After incubation with SVB for 24 hours, 
the cells were lysed and the cellular proteins were then separated in SDS-polyacrylamide gels, after which they were 
transferred onto nitrocellulose membranes. The membranes were then probed with the indicated antibodies and the 
proteins were visualized using an ECL detection system. Actin was used as the internal control.
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treatment with SVB increased the activity of the 
caspases in a concentration-dependent manner. Sub-
sequent Western blot analysis revealed that progres-
sive proteolytic cleavage of the poly(ADP-ribose) 
polymerase (PARP) and β-catenin proteins, which are 
downstream targets of the activated caspase-3 
[24,25], occurred in A549 cells that were treated 
with SVB, and that this cleavage was induced in a 
concentration-dependent manner [Figure 5A]. These 
results indicate that activation of caspases plays 
an important role in SVB-induced apoptosis in A549 
cells.
4. Discussion
In recent years, various studies have been conducted 
that show how Chan Su may impinge on cellular sig-
naling pathways and often may recruit them to in-
duce apoptosis in cancer cells [14−22]. However, the 
mechanisms responsible for the apoptotic effects of 
Chan Su have not yet been determined. In the present 
study, SVB was shown to significantly inhibit prolif-
eration and cell viability and induced mitochondrial 
damage and apoptosis in human lung carcinoma 
A549 cells.
Mitochondria have recently been suggested as a 
possible target for anti-cancer drug induced apopto-
sis. Since the discovery of Bcl-2, several mechanisms 
for the anti-apoptotic properties of this protein have 
been proposed [6−8]. The anti-apoptotic function of 
Bcl-2 against pro-apoptotic Bax may be explained by 
its ability to control several key steps involved in 
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Figure 4 Loss of MMP by SVB treatment of A549 cells. 
After being treated with SVB for 24 hours, the cells were 
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Figure 5 Activation of caspases and the degradation of the PARP and β-catenin protein by SVB treatment in A549 
cells. (A) After 24 hours incubation with SVB, the cells were lysed. The cellular proteins were separated by SDS-
polyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were probed with anti-
caspase-3, anti-caspase-8, anti-caspase-9, anti-PARP and anti-β-catenin antibodies. The proteins were visualized 
using an ECL detection system. Actin was used as the internal control. (B) The cell lysates from the cells grown under 
the same conditions as (A) were assayed for in vitro caspase-3, caspase-8 and caspase-9 activity using the substrates 
DEVD-pNA, IETD-pNA and LEHD-pNA, respectively. The concentrations of the fluorescent products released were 
measured. Data are expressed as mean ± SD of three independent experiments. For statistical analysis, t-test was 
performed (*, p < 0.05).
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death signaling. Bcl-2 can form ion channels in mito-
chondrial membranes, which may allow it to control 
apoptosis by influencing the permeability of the 
intracellular membranes and release of substances 
into the cytoplasm [4,8,9]. These observations dem-
onstrated that the Bcl-2 family significantly regu-
lates apoptosis either as an activator (Bax) or as an 
inhibitor (Bcl-2); therefore, it has been suggested 
that the Bax/Bcl-2 ratio is a key factor in regulation 
of the apoptotic process [4−9]. The results of this 
study indicate that SVB treatment results in the 
induction of apoptosis in A549 cells, which was 
confirmed by characteristic morphological changes, 
chromatin condensation and increases in the num-
ber of sub-G1 cells (Figure 2). Therefore, we first 
evaluated the effects of SVB on the levels of proteins 
in the Bcl-2 family in A549 cells to test the mecha-
nism by which SVB-induced apoptosis occurs. Our 
results demonstrate that SVB did not alter expres-
sion levels of pro-apoptotic Bax but did markedly 
down-regulate the expression of anti-apoptotic Bcl-2 
(Figure 3), which was associated with a reduction 
in the level of MMP (Figure 4). The data indicates 
that the SVB increased Bax/Bcl-2 ratio and induced 
mitochondrial dysfunction lead to apoptosis in 
A549 cells.
The results of many studies have suggested that 
reduction of Bcl-2 or induction of Bax leads to the 
release of cytochrome c from the mitochondria 
into the cytosol, as well as an increase in the ac-
tivity of caspases [5,6]. The caspases are a family 
of proteins that are one of the main executors of 
the apoptotic process in both the extrinsic (death 
receptor-mediated) and intrinsic (mitochondrial-
mediated) apoptotic pathway. They belong to a 
group of enzymes known as cysteine proteases and 
exist within the cell as inactive pro-forms or zymo-
gens. Caspase signaling is initiated and propagated 
by proteolytic autocatalysis, as well as the cleav-
age of downstream caspases and substrates [3−6]. 
The death receptor pathway is initiated by binding 
of ligands to the death receptors on the cell surface, 
which then activates caspase-8 and then cleavage 
of Bid (tBid), which further activates a series of 
caspase cascades, resulting in apoptotic cell death 
[7−9]. However, changes in the mitochondrial in-
tegrity in response to a broad range of physical and 
chemical stimuli can trigger the intrinsic pathway 
of apoptosis [2,6,9,26]. Once in the cytosol, cyto-
chrome c can activate caspase-9, which in turn 
cleaves and activates the key executioner, caspase-3, 
which is either partially or totally responsible for 
the proteolytic cleavage of many key proteins in-
cluding PARP and β-catenin that are important for 
cell viability but also serves as markers of apoptosis 
when cleaved [24,25]. Further studies have dem-
onstrated that SVB increased the levels of FasL and 
DR4 expression, key regulators of the extrinsic apop-
totic pathway, and the enzymatic activity of both 
extrinsic and intrinsic caspase cascades such as 
caspase-8 and -9. In addition, the decreased levels 
of IAP family proteins and down regulation of length 
Bid expression were observed in SVB-treated A549 
cells (Figure 5). These results indicate that SVB 
may activate the extrinsic apoptotic pathway and 
increase mitochondrial dysfunction, which, in turn, 
results in the activation of caspase-9, leading to 
the activation of caspase-3, which is also associated 
with the degradation of caspase-3 target proteins.
In summary, our results indicate that SVB strongly 
suppresses the proliferation of A549 cells by induc-
tion of apoptosis through activation of the mito-
chondrial mediated-intrinsic caspase pathway along 
with the death receptor-mediated extrinsic path-
way. Although further studies are needed, we believe 
that SVB is a promising candidate for cancer che-
moprevention and/or chemotherapy.
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